Loperamide is a peripheral
opiate agonist that can cause apoptosis and G2/M arrest in human cancer cell lines and may
sensitize cells to chemotherapy. The objectives of this study were to investigate the
effects of loperamide on viability, apoptosis and cell cycle kinetics in canine cancer
cells and to establish whether the drug sensitizes cells to doxorubicin. Cell viability
was assessed using Alamar Blue. Cell death and cell cycle were studied using flow
cytometry with 7-Aminoactinomycin-D (7-AAD) and propidium iodide (PI), respectively.
Loperamide decreased cell viability in a dose-dependent fashion and was most effective
against canine osteosarcoma cells. In all cell lines, it induced a dose and time dependent
apoptosis and resulted in accumulation in G0/G1. When co-incubated with doxorubicin,
loperamide induced a synergistic cell kill in canine carcinoma cells. Investigation is
warranted into the role of loperamide in the treatment of canine cancer.